Ask AI
CDK4/6 Inhibitors HR Positive HER2 Negative EBC

CE

Case Challenge: Optimizing Patient–Provider Communication About CDK4/6 Inhibitors for Treatment of HR+/HER2- EBC

Physician Assistants: maximum of 1.00 hour of AAPA Category 1 CME credit

Registered Nurses: 1.00 Nursing contact hour

Released: May 22, 2026

Expiration: November 21, 2026

Activity

Progress
1 2
Course Completed

Case Follow-up
PK is receptive to this adjuvant treatment approach and is aware that others in her support group are receiving similar therapies. She is interested in learning more about the clinical benefits of adding a CDK4/6 inhibitor to her regimen.

Which of the following would you be sure to discuss with PK to help her accurately understand the role of adjuvant therapy with CDK4/6 inhibitors?